Home > Financial Ratios > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
SHUKRA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SHUKRA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 56.0215.782.974.239.02

What is the latest EV/Core EBITDA ratio of SHUKRA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SHUKRA PHARMACEUTICALS is 56.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202556.02
Mar202415.78
Mar20232.97
Mar20224.23
Mar20219.02

How is EV/Core EBITDA of SHUKRA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 56.02
255.01
Mar2024 15.78
431.31
Mar2023 2.97
-29.79
Mar2022 4.23
-53.10
Mar2021 9.02 -

Other Financial Ratios of SHUKRA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹1,525.6 Cr 9.3% -15.9% 68.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹98,892.8 Cr 2.6% -7.4% -16.3% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

9.3%

-15.9%

68.5%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses